Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

Recruiting now · Not applicable

Conditions studied: Obstructive Sleep Apnea, Obstructive Sleep Apnea of Adult

In brief

Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on cardiovascular and metabolism-related measures to see if it affects patients' risk of medical problems associated with obstructive sleep apnea (OSA).

Key facts

Study ID
NCT06720545
Run by
Columbia University
People needed
60
Starts
2025-01-05
Expected to finish
2028-01-01
Last updated by the study team
2025-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.